Login / Signup

Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years.

Maxime JullienBenoit TessoulinHervé GhesquièresLucie ObericFranck MorschhauserHervé TillyVincent RibragThierry LamyCatherine ThieblemontBruno VillemagneRémy GressinKamal BouabdallahCorinne HaiounGandhi DamajLuc-Matthieu ForneckerJean-Marc Schiano De ColellaPierre FeugierOlivier HermineGuillaume CartronChristophe BonnetMarc AndréClement BaillyRené-Olivier CasasnovasSteven Le Gouill
Published in: Cancers (2021)
After training on a series of 190 patients, the DLASA achieved a Dice coefficient of 0.97 ± 0.03. In the cohort, the median skeletal muscle index was 50.2 cm2/m2 and median muscle attenuation (MA) was 36.1 Hounsfield units (HU). No impact of sarcopenia was found on either progression free survival (PFS) or overall survival (OS). Muscular hypodensity, defined as MA below the tenth percentile according to sex, was associated with a lower OS and PFS, respectively (HR = 2.80 (95% CI 1.58-4.95), p < 0.001, and HR = 2.22 (95% CI 1.43-3.45), p < 0.001). Muscular hypodensity appears to be an independent risk factor for mortality in DLBCL and because of DLASA can be estimated in routine practice.
Keyphrases